Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Name: Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia
Published: 2018
License: Public Domain

Niguarda Hospital · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

chemotherapy overall-survival

core binding factor acute myeloid leukemia (cbf-aml), midostaurin, chemotherapy, relapse incidence, overall survival, disease free survival, minimal residual disease monitoring, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Related documents